William Blair Investment Management portfolio manager Jim Golan joined TD Ameritrade Network’s Morning Trade Live to discuss the tech securities drawing attention in the midst of earnings season.

Investment Management
William Blair Investment Management portfolio manager Jim Golan joined TD Ameritrade Network’s Morning Trade Live to discuss the tech securities drawing attention in the midst of earnings season.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of Ultragenyx Pharmaceutical Inc. (RARE $35.66), a commercial-stage, modality-agnostic biotechnology company specializing in developing therapies for the treatment of rare and ultrarare genetic diseases.
William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, announced today the continued growth of the firm’s Private Capital Advisory team in Europe with the addition of industry veteran Delaney Brown.